the great plains laboratory, inc. | operating worldwide
The Great Plains Laboratory, Inc. is a world leader in providing testing for metabolic, genetic, mitochondrial, and environmental factors in chronic illnesses. We offer a variety of state-of-the-art metabolic and genetic tests such as the Organic Acids Test, GPL-TOX (Toxic Non-Metal Chemical Profile), IgG Food Allergies Test, and our newest test the GPL-Mycotox Profile. Our ultimate goal is to help you provide your patients with the most personalized medicine possible and improve their quality of life. To find a specialist or to obtain a physician referral, contact our customer service department at 913-341-8949 or click here.
Free 30 minute phone consultations are available to assist in the interpretation of your test results.
Since releasing our GPL-MycoTOX Profile, we’ve been able to help accurately assess exposure to several common mycotoxins from mold. We have also now discovered strong correlations between specific markers on the Organic Acids Test and mycotoxin exposure. In this webinar, Dr. Shaw will review those correlations, including evidence in the literature linking them to health conditions such as autism and Parkinson’s disease. He will also discuss a recent case of autism that was rapidly recovered after antifungal treatment.
William Shaw received his Ph.D. in biochemistry and human physiology from the Medical University of South Carolina and is board certified in clinical chemistry and toxicology. Dr. Shaw has supervised large endocrinology, nutritional biochemistry, toxicology, and immunology departments in positions at the Centers for Disease Control (CDC) and Smith Kline Laboratories. As the Director of The Great Plains Laboratory, Inc. in Lenexa, Kansas, he specializes in providing diagnostic tools aiding in the diagnosis and treatment of mental health disorders, mitochondrial disorders, neurological diseases, chronic health issues, and immune diseases.
Individuals exposed to the herbicide glyphosate have a higher risk of digestive system problems, microbiome imbalance and even clostridia bacteria overgrowth. These issues can contribute to the problem of small intestine bacterial overgrowth (SIBO).
The methylation cycle is an important biochemical system linked to brain, nervous system and immune function, cardiovascular health, energy production and detoxification. There are key components in the methylation cycle, that when damaged, can contribute to a host of chronic health disorders. This lecture will focus on the adverse effects certain toxins can cause with methylation.
The Organic Acids Test (OAT) has many markers indicating invasive yeast and candida overgrowth. There are also markers on the OAT specific for mold exposure, digestive mold overgrowth and potential toxicity from mold toxins called Mycotoxins. This lecture will discuss these markers, as well as correlate information to the Great Plains Laboratory Myco-TOX profile.
The Organic Acids Test (OAT) has over 70 markers linked to various biochemical pathways, as well as toxic compounds linked to candida, bacteria, etc. There is often a lot of attention given to the most commonly seen markers on the OAT such as arabinose from candida and high oxalates. This lecture will focus on some of the other ‘lesser known’ markers such as mandelic, kynurenic and those in the amino acids metabolites sections and others.